Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 193

1.

Toward a marker of upper motor neuron impairment in amyotrophic lateral sclerosis: A fully automatic investigation of the magnetic susceptibility in the precentral cortex.

Contarino VE, Conte G, Morelli C, Trogu F, Scola E, Calloni SF, Sanmiguel Serpa LC, Liu C, Silani V, Triulzi F.

Eur J Radiol. 2020 Jan 11;124:108815. doi: 10.1016/j.ejrad.2020.108815. [Epub ahead of print]

PMID:
31945675
2.

A Novel Mutation of GFAP Causing Adult-Onset Alexander Disease.

Ciammola A, Sangalli D, Sassone J, Poletti B, Carelli L, Banfi P, Pappacoda G, Ceccherini I, Grossi A, Maderna L, Pingue M, Girotti F, Silani V.

Front Neurol. 2019 Nov 6;10:1124. doi: 10.3389/fneur.2019.01124. eCollection 2019.

3.

Inter-Species Differences in Regulation of the Progranulin-Sortilin Axis in TDP-43 Cell Models of Neurodegeneration.

Gumina V, Onesto E, Colombrita C, Maraschi A, Silani V, Ratti A.

Int J Mol Sci. 2019 Nov 22;20(23). pii: E5866. doi: 10.3390/ijms20235866.

4.

A Novel Approach for Investigating Parkinson's Disease Personality and Its Association With Clinical and Psychological Aspects.

Carelli L, Solca F, Torre S, Pasquini J, Morelli C, Pezzati R, Mancini F, Ciammola A, Silani V, Poletti B.

Front Psychol. 2019 Oct 11;10:2265. doi: 10.3389/fpsyg.2019.02265. eCollection 2019.

5.

Carotid artery stenting is safe and effective for symptomatic patients with acute coronary syndrome.

Casana R, Tolva VS, Odero A Jr, Malloggi C, Silani V, Parati G.

Catheter Cardiovasc Interv. 2019 Aug 13. doi: 10.1002/ccd.28445. [Epub ahead of print]

PMID:
31410994
6.

Neurochemical biomarkers in amyotrophic lateral sclerosis.

Verde F, Silani V, Otto M.

Curr Opin Neurol. 2019 Oct;32(5):747-757. doi: 10.1097/WCO.0000000000000744.

PMID:
31403480
7.

TDP-43 and NOVA-1 RNA-binding proteins as competitive splicing regulators of the schizophrenia-associated TNIK gene.

Gumina V, Colombrita C, Fallini C, Bossolasco P, Maraschi AM, Landers JE, Silani V, Ratti A.

Biochim Biophys Acta Gene Regul Mech. 2019 Sep;1862(9):194413. doi: 10.1016/j.bbagrm.2019.194413. Epub 2019 Aug 2.

PMID:
31382054
8.

Comparative Analysis of C9orf72 and Sporadic Disease in a Large Multicenter ALS Population: The Effect of Male Sex on Survival of C9orf72 Positive Patients.

Trojsi F, Siciliano M, Femiano C, Santangelo G, Lunetta C, Calvo A, Moglia C, Marinou K, Ticozzi N, Ferro C, Scialò C, Sorarù G, Conte A, Falzone YM, Tortelli R, Russo M, Sansone VA, Chiò A, Mora G, Silani V, Volanti P, Caponnetto C, Querin G, Sabatelli M, Riva N, Logroscino G, Messina S, Fasano A, Monsurrò MR, Tedeschi G, Mandrioli J.

Front Neurosci. 2019 May 17;13:485. doi: 10.3389/fnins.2019.00485. eCollection 2019.

9.

Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS).

Mandrioli J, Crippa V, Cereda C, Bonetto V, Zucchi E, Gessani A, Ceroni M, Chio A, D'Amico R, Monsurrò MR, Riva N, Sabatelli M, Silani V, Simone IL, Sorarù G, Provenzani A, D'Agostino VG, Carra S, Poletti A.

BMJ Open. 2019 May 30;9(5):e028486. doi: 10.1136/bmjopen-2018-028486.

10.

A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis.

Shefner JM, Cudkowicz ME, Hardiman O, Cockcroft BM, Lee JH, Malik FI, Meng L, Rudnicki SA, Wolff AA, Andrews JA; VITALITY-ALS Study Group.

Amyotroph Lateral Scler Frontotemporal Degener. 2019;0(0):1-11. doi: 10.1080/21678421.2019.1612922. Erratum in: Amyotroph Lateral Scler Frontotemporal Degener. 2019 Jul 14;:1.

PMID:
31081694
11.

PON1 is a disease modifier gene in amyotrophic lateral sclerosis: association of the Q192R polymorphism with bulbar onset and reduced survival.

Verde F, Tiloca C, Morelli C, Doretti A, Poletti B, Maderna L, Messina S, Gentilini D, Fogh I, Ratti A, Silani V, Ticozzi N.

Neurol Sci. 2019 Jul;40(7):1469-1473. doi: 10.1007/s10072-019-03834-2. Epub 2019 Mar 22.

PMID:
30903418
12.

Three-year outcomes after carotid artery revascularization: Gender-related differences.

Casana R, Malloggi C, Tolva VS, Odero A Jr, Bulbulia R, Halliday A, Silani V, Parati G.

Vascular. 2019 Oct;27(5):459-467. doi: 10.1177/1708538119836312. Epub 2019 Mar 12. No abstract available.

PMID:
30860445
13.

Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials.

van den Berg LH, Sorenson E, Gronseth G, Macklin EA, Andrews J, Baloh RH, Benatar M, Berry JD, Chio A, Corcia P, Genge A, Gubitz AK, Lomen-Hoerth C, McDermott CJ, Pioro EP, Rosenfeld J, Silani V, Turner MR, Weber M, Brooks BR, Miller RG, Mitsumoto H; Airlie House ALS Clinical Trials Guidelines Group.

Neurology. 2019 Apr 2;92(14):e1610-e1623. doi: 10.1212/WNL.0000000000007242. Epub 2019 Mar 8.

14.

Provisional best practices guidelines for the evaluation of bulbar dysfunction in amyotrophic lateral sclerosis.

Pattee GL, Plowman EK, Focht Garand KL, Costello J, Brooks BR, Berry JD, Smith RA, Atassi N, Chapin JL, Yunusova Y, McIlduff CE, Young E, Macklin EA, Locatelli ER, Silani V, Heitzman D, Wymer J, Goutman SA, Gelinas DF, Perry B, Nalipinski P, Stipancic K, O'Brien M, Sullivan SL, Pioro EP, Gargiulo G, Green JR; Contributing Members of the NEALS Bulbar Subcommittee.

Muscle Nerve. 2019 May;59(5):531-536. doi: 10.1002/mus.26408. Epub 2019 Jan 22.

PMID:
30620104
15.

Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation.

Castelnovo V, Caminiti SP, Riva N, Magnani G, Silani V, Perani D.

Neurol Sci. 2019 Mar;40(3):515-521. doi: 10.1007/s10072-018-3685-7. Epub 2018 Dec 15.

PMID:
30554355
16.

Sexuality and intimacy in ALS: systematic literature review and future perspectives.

Poletti B, Carelli L, Solca F, Pezzati R, Faini A, Ticozzi N, Mitsumoto H, Silani V.

J Neurol Neurosurg Psychiatry. 2019 Jun;90(6):712-719. doi: 10.1136/jnnp-2018-319684. Epub 2018 Dec 11. Review.

PMID:
30538137
17.

Response to the commentary "The effect of C9orf72 intermediate repeat expansions in neurodegenerative and autoimmune diseases" by Biasiotto G and Zanella I..

Tiloca C, Sorosina M, Esposito F, Peroni S, Colombrita C, Ticozzi N, Ratti A, Martinelli-Boneschi F, Silani V.

Mult Scler Relat Disord. 2019 Jan;27:79-80. doi: 10.1016/j.msard.2018.10.007. Epub 2018 Oct 14. No abstract available.

PMID:
30347338
18.

Does metabolic syndrome influence short and long term durability of carotid endarterectomy and stenting?

Casana R, Malloggi C, Tolva VS, Odero A Jr, Bulbulia R, Halliday A, Silani V.

Diabetes Metab Res Rev. 2019 Jan;35(1):e3084. doi: 10.1002/dmrr.3084. Epub 2018 Nov 7.

PMID:
30312002
19.

The role of clinical and neuroimaging features in the diagnosis of CADASIL.

Bersano A, Bedini G, Markus HS, Vitali P, Colli-Tibaldi E, Taroni F, Gellera C, Baratta S, Mosca L, Carrera P, Ferrari M, Cereda C, Grieco G, Lanfranconi S, Mazucchelli F, Zarcone D, De Lodovici ML, Bono G, Boncoraglio GB, Parati EA, Calloni MV, Perrone P, Bordo BM, Motto C, Agostoni E, Pezzini A, Padovani A, Micieli G, Cavallini A, Molini G, Sasanelli F, Sessa M, Comi G, Checcarelli N, Carmerlingo M, Corato M, Marcheselli S, Fusi L, Grampa G, Uccellini D, Beretta S, Ferrarese C, Incorvaia B, Tadeo CS, Adobbati L, Silani V, Faragò G, Trobia N, Grond-Ginsbach C, Candelise L; Lombardia GENS-group.

J Neurol. 2018 Dec;265(12):2934-2943. doi: 10.1007/s00415-018-9072-8. Epub 2018 Oct 11.

PMID:
30311053
20.

Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis.

Verde F, Steinacker P, Weishaupt JH, Kassubek J, Oeckl P, Halbgebauer S, Tumani H, von Arnim CAF, Dorst J, Feneberg E, Mayer B, Müller HP, Gorges M, Rosenbohm A, Volk AE, Silani V, Ludolph AC, Otto M.

J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):157-164. doi: 10.1136/jnnp-2018-318704. Epub 2018 Oct 11.

PMID:
30309882

Supplemental Content

Loading ...
Support Center